ClinConnect ClinConnect Logo
Search / Trial NCT05403151

Controls and Healthy Vasculature Initiative

Launched by NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI) · Jun 2, 2022

Trial Information

Current as of July 04, 2025

Recruiting

Keywords

Sample Collection Vascular Blood Inflammation Thrombosis Natural History

ClinConnect Summary

The "Controls and Healthy Vasculature Initiative" is a clinical trial aimed at understanding diseases related to blood, blood vessels, and the immune system. Researchers need to compare blood samples from healthy individuals and those with these diseases to learn more about how they affect health and to improve testing methods. By collecting blood from healthy volunteers, the study hopes to establish what is considered "normal" in these tests.

To participate, you must be a healthy adult aged 18 or older, and you cannot be pregnant or nursing. You'll have a quick telehealth visit or phone call to go over your health history before coming to the NIH Clinical Center to donate blood. During your visit, about 10 tablespoons of blood will be drawn, and some samples may be used for future research. You can choose to return for repeat visits over the next 10 years if you wish, and you will receive $50 for each blood collection visit. This study is not only important for advancing medical research but also helps ensure new tests are accurate and effective.

Gender

ALL

Eligibility criteria

  • * INCLUSION CRITERIA:
  • In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Stated willingness to comply with all study procedures
  • Aged 18 years and older
  • Ability of subject to understand and the willingness to sign a written informed consent document
  • Self-reported in good general health
  • EXCLUSION CRITERIA:
  • An individual who, by self-report, meets the following criteria will be excluded from participation in this study:
  • -Current pregnancy or lactation

About National Heart, Lung, And Blood Institute (Nhlbi)

The National Heart, Lung, and Blood Institute (NHLBI) is a leading component of the National Institutes of Health (NIH), dedicated to advancing research and clinical trials focused on cardiovascular, pulmonary, and hematologic diseases. With a mission to improve public health through innovative research, the NHLBI supports a wide range of studies aimed at understanding, preventing, and treating heart and lung conditions. By collaborating with academic institutions, healthcare providers, and patient communities, the NHLBI strives to translate scientific discoveries into effective clinical practices, ultimately enhancing the quality of life for individuals affected by these critical health issues.

Locations

Bethesda, Maryland, United States

Patients applied

0 patients applied

Trial Officials

Yogendra Kanthi, M.D.

Principal Investigator

National Heart, Lung, and Blood Institute (NHLBI)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials